The Augmented versus Routine approach to Giving Energy Trial (TARGET): A feasibility trial in the critically ill
Dr Marianne Chapman
112 participants
Jan 24, 2013
Interventional
Conditions
Summary
This trial is a feasibility/ pilot study to establish if the administration of the treatment enteral feed (1.5 kcal/ml) increases mean daily energy delivery (kilocalorie per day) by > or equal to 20% compared to the control (1.0 kcal/ml). The study will provide baseline data to allow for the planning and funding of a larger multi centre trial to determine if delivery of additional energy to critically ill adults over the first 10 days of their ICU stay affects clinically important outcomes. Following the 10 day study treatment period, if required, patients in both groups will receive additional nutrition according to the centres standard care. The pilot study will be conducted in 6 centres in Australia with 100 patients enrolled over a six month period.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
1.5 kilocalorie per ml enteral feed formulation delivered via naso-gastric tube at a goal rate of 1ml per kilogram per hour (capped at 100ml/hr) continuously for a maximum of 10 days. Blinded enteral nutrition will cease prior to day 10 if one of the following occur: cessation of enteral nutrition by the treating clinicians, patient is discharged from the ICU, treating clinician decides that it is in the patients best interest to cease the study intervention or informed consent is withdrawn.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12611000793910